News
NNNN
28.84
+1.05%
0.30
Weekly Report: what happened at NNNN last week (0406-0410)?
Weekly Report · 1d ago
Anbio Biotechnology Posts Solid FY25 Results, Diversifies Portfolio
Benzinga · 5d ago
Weekly Report: what happened at NNNN last week (0330-0403)?
Weekly Report · 04/06 09:54
Weekly Report: what happened at NNNN last week (0323-0327)?
Weekly Report · 03/30 09:55
Weekly Report: what happened at NNNN last week (0316-0320)?
Weekly Report · 03/23 09:52
Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum
Barchart · 03/17 15:30
Weekly Report: what happened at NNNN last week (0309-0313)?
Weekly Report · 03/16 09:51
Weekly Report: what happened at NNNN last week (0302-0306)?
Weekly Report · 03/09 09:53
Anbio Biotechnology: Improved Margins, Still Priced For Growth That Isn't Showing Up
Seeking Alpha · 03/03 19:50
Weekly Report: what happened at NNNN last week (0223-0227)?
Weekly Report · 03/02 09:52
Weekly Report: what happened at NNNN last week (0216-0220)?
Weekly Report · 02/23 09:52
Anbio Biotechnology Replaces Auditor to Safeguard 2025 Reporting Timeline
TipRanks · 02/17 22:54
Weekly Report: what happened at NNNN last week (0209-0213)?
Weekly Report · 02/16 09:51
Weekly Report: what happened at NNNN last week (0202-0206)?
Weekly Report · 02/09 09:53
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 02/05 12:05
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 02/03 17:05
Anbio Biotechnology rises 20.0%
TipRanks · 02/03 17:05
Anbio Biotechnology trading resumes
TipRanks · 02/02 18:40
Weekly Report: what happened at NNNN last week (0126-0130)?
Weekly Report · 02/02 09:52
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 01/29 21:05
More
Webull provides a variety of real-time NNNN stock news. You can receive the latest news about ANBIO BIOTECHNOLOGY through multiple platforms. This information may help you make smarter investment decisions.
About NNNN
Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).